Gene Query: EIF3K

Dataset Description Geneva Score
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 48.46
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 44.68
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 33.2
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 29.43
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 28.72
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 24.19
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 23.75
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 23.75
NRDE2 negatively regulates nuclear exosome functions 23.13
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 22.52
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 21.77
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 21.77
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 20.62
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 20.26
Mitochondrial dsRNA triggers antiviral signalling in humans 19.96
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 19.19
TGF-β regulation of miRNA expression in pancreatic cancer 18.47
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 18.03
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 17.96
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 17.96
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 17.91
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 17.33
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 17.33
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 17.21
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 17.04
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 16.96
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 16.96
Global analysis of enhancer targets: Mosaic-seq 16.71
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 16.62
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 16.6
Role of XRN2 ribonucleolytic activity in RNA metabolism 16.25
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 16.12
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 15.86
miR941 overexpression experiment 15.84
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 15.23
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 14.76
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 14.67
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 14.34
TCF7L1 knockdown in pancreatic cancer 14.29
RNA sequencing of primary human platelets and in vitro cell lines 14.23
U1 snRNP telescripting regulates size-function stratified human genome 13.83
Identification of Atrial Fibrillation associated genes and functional non-coding variants 13.67
The pioneer factor CEBPA modulates vitamin D signaling 13.59
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 13.59
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 13.58
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 13.49
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 13.31
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 13.02
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 12.9
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 12.79
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 12.79
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 12.78
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 12.72
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 12.65
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 12.58
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 12.56
LncRNA expression profiling of ischemic stroke patients 12.44
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 12.37
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 12.35
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 12.35
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 12.18
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 12.13
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 12.13
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 11.87
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 11.83
Determining mRNA half-lives on a transcriptome-wide scale 11.79
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 11.72
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 11.63
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 11.61
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 11.61
CROP-Seq in Primary Human T Cells 11.6
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 11.58
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 11.58
mRNA expression profile of Lymphocytes 11.56
Global transcriptome analysis of HAP1 cells 11.51
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 11.34
Effect of Influenza virus infection on lncRNA expression in A549 cells 11.24
11.22
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 11.18
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 11.04
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 10.99
RNA-seq of YB5 cells treated with Proscillaridin A 10.99
Role of microRNAs in the interaction between Salmonella and the host cell 10.92
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 10.85
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 10.77
Transcriptome analysis of U87 cells upon LINC00152 knockdown 10.72
3’ Uridylation Expands miRNA Target Repertoire 10.64
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 10.59
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 10.56
Integrating single-cell transcriptomic data across different conditions, technologies, and species 10.39
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 10.36
Tracking distinct RNA populations using efficient and reversible covalent chemistry 10.06
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 10.05
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 9.94
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 9.94
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 9.94
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 9.94
MCF10A H-Ras RNA-Seq 9.87
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 9.86
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 9.86
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 9.84
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 9.84
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 9.84
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 9.83
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 9.83
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 9.82
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 9.67
RNA-seq in transgenic cells 9.66
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 9.63
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 9.61
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 9.61
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 9.56
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 9.56
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 9.54
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 9.5
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 9.49
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 9.49
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 9.45
Stem and effector CD8 T-cells from human cancers 9.43
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 9.42
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 9.42
The human blood-nerve barrier transcriptome 9.41
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 9.38
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 9.32
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 9.32
hnRNP C is a key regulator of protein synthesis in mitosis 9.28
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 9.24
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 9.17
Identification of transcription start sites for human A549 cell line using ReCappable-seq 9.06
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 9.03
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 9.0
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 8.97
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 8.9
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 8.86
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 8.86
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 8.8
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 8.78
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 8.75
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 8.72
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 8.72
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 8.7
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 8.68
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 8.61
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 8.6
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 8.6
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 8.55
Lysine benzoylation is a novel histone mark 8.52
Lysine benzoylation is a novel histone mark [RNA-seq] 8.52
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 8.5
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 8.44
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 8.42
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 8.39
RNA-Seq with and without RNase treatment in PCa cell lines 8.32
Identification of renal resident macrophages across species 8.29
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 8.25
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 8.2
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 8.19
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 8.1
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 8.07
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 8.06
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 8.06
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 8.06
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 8.05
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 8.02
Transcriptome analysis of H9 hESC derived cerebral organoids 8.01
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 7.99
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 7.99
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 7.98
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.92
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 7.87
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 7.87
Control of prostate tumour growth by the long non-coding RNA GHSROS 7.85
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 7.85
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 7.83
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 7.83
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 7.75
HNF1 regulates critical functions of the human epididymis epithelium. 7.75
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 7.72
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 7.72
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 7.72
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 7.7
The effect of PPARG inhibition on human angiomyolipoma cells 7.68
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 7.68
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 7.67
Gene expression analysis of immortalized human liver progenitor-like cells in culture 7.66
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 7.62
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 7.62
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 7.51
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 7.5
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 7.41
Generation of KRAS signatures using immortalized isogenic lung cells. 7.36
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 7.33
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 7.32
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 7.27
Differential Gene Expression between MCF10A and MCF7 cells 7.2
Differential gene expression of human melanoma cells [RNA-seq] 7.11
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 7.11
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 7.06
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 7.05
Expression profiling of MCF-7 cells with treatment of TCDD 7.05
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 7.03
Differential Protein Occupancy Profiling of the mRNA Transcriptome 7.0
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 6.94
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 6.92
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 6.76
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 6.75
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 6.72
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 6.72
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 6.71
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 6.71
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 6.68
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 6.67
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 6.58
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 6.56
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 6.55
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 6.55
An optimization system for isolating and sequencing of single human colon cancer cells 6.52
SLIGRL-induced gene expression changes in NHEK cells 6.46
An siRNA screen identifies CHD4 as a target for epigenetic therapy 6.39
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 6.39
Microprocessor mediates transcription termination in long noncoding microRNA genes 6.36
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 6.35
Differential gene expression profiles in imatinib-resistant cell lines 6.31
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 6.28
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 6.27
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 6.27
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 6.27
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 6.16
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 6.16
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 6.11
Regulatory network controlling tumor-promoting inflammation in human cancers 6.07
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 6.07
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.04
Knockdown of ADNP in HCT116 colon cancer cells 5.96
Landscape and variation of RNA secondary structure across the human transcriptome 5.92
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 5.91
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 5.91
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 5.9
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 5.89
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 5.82
Genome-wide discovery of human splicing branchpoints [RNAse] 5.81
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 5.8
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 5.73
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 5.71
The transcriptome and chromatin accessbility landscape of mammalian germline 5.7
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 5.68
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.68
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 5.68
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 5.68
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 5.67
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 5.61
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 5.55
Transcription elongation regulates genome 3D structure 5.53
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 5.52
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 5.48
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 5.39
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 5.39
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 5.34
Ribosome profiling upon inhibition of eIF4A 5.3
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 5.3
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 5.28
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 5.23
RNA editing in nascent RNA affects pre-mRNA splicing 5.22
METTL3 and WTAP 5.2
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 5.18
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 5.14
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 5.11
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 5.1
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 5.09
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 5.06
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 4.8
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.79
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 4.79
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.76
Solid phase chemistry to covalently and reversibly capture thiolated RNA 4.75
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 4.74
Comparative Analysis of Cas9 Activators Across Multiple Species 4.69
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 4.66
Universal alternative splicing of noncoding exons 4.63
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 4.63
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 4.54
Hepatitis C virus functionally sequesters miR-122 4.54
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 4.53
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 4.46
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 4.43
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.38
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.38
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.36
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.33
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 4.3
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 4.29
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 4.29
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.27
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.27
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 4.26
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 4.25
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 4.24
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 4.24
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 4.23
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 4.21
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 4.21
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 4.09
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.03
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  4.01
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 4.01
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 3.98
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 3.97
Lineage specific differentiation is influenced by state of human pluripotency 3.9
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 3.9
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 3.9
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.89
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 3.87
ADAR1-editing of cellular and measles virus-derived duplex RNA 3.87
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.87
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 3.86
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 3.86
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 3.85
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 3.77
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 3.74
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.71
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.7
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 3.69
siRNA-mediated knockdown 3.68
Mapping interactions for the TNIP2 hub protein 3.64
Transcriptome analysis of peripheral blood monocytes 3.63
A20 regulates canonical wnt-signaling through an interaction with RIPK4 3.56
Dilated cardiomyopathy vs Myocarditis 3.49
Positively selected enhancer elements endow tumor cells with metastatic competence 3.46
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 3.45
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 3.45
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 3.39
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 3.37
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 3.35
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 3.35
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 3.34
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.34
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.32
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 3.28
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.26
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.25
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 3.25
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 3.23
NAPRT activation of macrophages 3.22
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.21
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.2
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.2
RNA-sequencing of healthy human skeletal myocytes 3.1
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.07
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.03
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 3.03
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 2.99
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 2.97
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 2.97
Transcriptomic analysis of the HOTAIR-regulated genes 2.91
Human cells contain natural double-stranded RNAs with potential regulatory capacity 2.91
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.82
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.82
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 2.8
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 2.79
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.78
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.78
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 2.77
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 2.75
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.75
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.75
Total RNA-Seq data from leukemic patients with complex structural variants 2.75
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.68
Metastasis in triple-negative breast cancer 2.68
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 2.66
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 2.64
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.63
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.63
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 2.59
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 2.57
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.55
A single-cell transcriptome atlas of the human pancreas 2.55
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 2.52
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 2.51
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.51
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.51
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 2.49
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 2.49
Interaction between mitoNEET and NAF-1 in cancer cells 2.46
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.4
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.34
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.34
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 2.33
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 2.32
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 2.32
BET bromodomain inhibition 2.24
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 2.24
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 2.22
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 2.22
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 2.21
Transcriptional landscape changes during human embryonic stem cell derivation 2.21
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 2.2
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 2.17
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 2.16
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.1
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 1.94
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 1.94
MARCKS and lnc-MARCKS act as inflammation regulators 1.93
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.93
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 1.87
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.87
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.86
RNAseq of cell lines with knocked in ESR1 mutations 1.85
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.8
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.8
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.79
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.79
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.75
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 1.68
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.67
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.67
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.63
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.62
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 1.58
Transcriptome-wide response to synthetic chromatin protein PcTF 1.53
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.49
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 1.48
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.47
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.46
RNA Sequencing of Human iPS derived Cardiomyocytes 1.41
The bromodomain protein BRD4 regulates splicing during heat shock 1.35
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.33
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.33
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.32
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.28
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.28
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 1.24
Induced DNA demethylation, genome instability and transcription 1.2
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.2
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.18
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 1.1
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 1.1
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.09
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.07
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.07
Gene expression analysis of human adenomas. 1.07
Human Tfh cell RNA bulk sequencing 1.07
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.04
Gene expression profiling in metabolically heterogeneous human lung tumors 1.01
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 0.99
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.98
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.97
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.97
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.97
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.94
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.87
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.87
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 0.86
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.76
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.75
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.68
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 0.67
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.65
Exogenous rescue of KLHL9 in SF210 cell line 0.64
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.61
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.6
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.6
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.6
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.6
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.59
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.59
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.51
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.51
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.49
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.48
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.46
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.44
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.44
The role of m6A/m-RNA methylation in stress response regulation 0.44
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.43
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.42
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.4
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 0.38
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 0.38
Global transcriptome analysis of WT versus HEB-/- hESCs 0.38
Single-cell analysis of human kidney organoids 0.34
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.34
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.32
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.31
Gene expression alterations of pancreatic intraepithlial neoplasia 0.25
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.24
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.24
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 0.2
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.2
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.17
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.17
O-glcnAc reprograms cellular energetics 0.12
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.11
Genome-wide analysis of the Integrator complex 0.1
Genome-wide analysis of the Integrator complex (HTS) 0.1
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.09
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.07
Transcriptomic analysis of human macrophages in 3D 0.03
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.03
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.03
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation